Recent evidence shows that PKMζ, an atypical PKC isoform that plays a pivotal role in the maintenance of LTP, may participate in the development of depression and might be one of the critical targets that mediate actions of antidepressants, suggesting that PKMζ might be a potential target for the treatment of depression. This evidence concerns the gene PRRT2 and major depressive disorder.